tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
Published 11 months ago • 660 plays • Length 6:24Download video MP4
Download video MP3
Similar videos
-
7:15
tnb-486: a novel bite being explored in r/r b-nhl
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
3:05
the clinical use of circulating tumor dna in t-cell lymphomas
-
3:37
advances in the management of follicular lymphoma in the frontline and relapsed settings
-
1:29
diagnosis and staging of follicular lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
2:27
ascembl: asciminib versus bosutinib in third-line treatment of cp-cml
-
0:45
difference between quality of life & patient-reported outcomes
-
1:09
interim analysis of anbal-cel for r/r dlbcl
-
9:41
subcutaneous epcoritamab in r/r b-cell non-hodgkin lymphoma
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
0:56
cnty-101 in follicular lymphoma: a case study from the elipse-1 trial
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
1:21
the future of lymphoma treatment – combining new therapies with molecular diagnosis
-
4:02
key therapeutic advances in follicular lymphoma
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
0:58
first-in-human trial of cln-978, a novel cd19 bispecific antibody, for the treatment of r/r b-nhl
-
1:21
work of the follicular lymphoma foundation